Title : Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).

Pub. Date : 2014 Apr 23

PMID : 24760190






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Aspirin use reduces the risk of colorectal neoplasia, at least in part, through inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase 2)-related pathways. Aspirin prostaglandin-endoperoxide synthase 2 Homo sapiens
2 Aspirin use reduces the risk of colorectal neoplasia, at least in part, through inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase 2)-related pathways. Aspirin prostaglandin-endoperoxide synthase 2 Homo sapiens
3 Aspirin use reduces the risk of colorectal neoplasia, at least in part, through inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase 2)-related pathways. Aspirin prostaglandin-endoperoxide synthase 2 Homo sapiens